CGT Asia 2026

We are in an era of breakthroughs in biomedicine. Cell and gene therapy, as a disruptive frontier field, is making many previously "incurable" diseases possible. It is no longer merely content with alleviating symptoms but is committed to correcting diseases at their root, representing a paradigm shift in the global pharmaceutical industry from "molecular drugs" to "live drugs".

Years of hard work have led to glory. Since the launch of the first summit, CGT Asia has always been in harmony with the industry and has been fortunate to witness and promote the magnificent development of the CGT field in Asia. Standing at the milestone of the 10th edition, the "CGT Asia 2026 - The 10th Asia Cell and Gene Therapy Innovation Summit" hosted by Tansi Biotech will be grandly held in Shanghai from April 1st to 2nd, 2026.

Partial data of the CGT Asia 2025 event (in percentage %)

This conference will deeply focus on the most cutting-edge developments in cell and gene drug research and development, analyze the development trends and integrated applications of core technologies such as immune cell therapy, gene therapy for rare diseases, gene editing, in vivo CAR-T technology, mesenchymal stem cells, and AAV vectors, and accelerate the transformation of innovative therapies from the laboratory to practical application. In addition, the summit will bring together Asia's top scientists, clinical researchers, business leaders and policy experts to jointly outline the development path and commercial future of cell and gene therapy in the next stage.